Business Description
Sinew Pharma Inc
ISIN : TW0006634009
Total Employee Number:
57Description
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 81.1 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 70.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -41.5 | |||||
3-Year EBITDA Growth Rate | 4.8 | |||||
3-Year EPS without NRI Growth Rate | 4.9 | |||||
3-Year FCF Growth Rate | 1.6 | |||||
3-Year Book Growth Rate | -9.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.76 | |||||
9-Day RSI | 53.1 | |||||
14-Day RSI | 50.42 | |||||
3-1 Month Momentum % | -5.5 | |||||
6-1 Month Momentum % | 59.33 | |||||
12-1 Month Momentum % | 28.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 46.43 | |||||
Quick Ratio | 46.43 | |||||
Cash Ratio | 45.22 | |||||
Days Sales Outstanding | 388.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | -0.08 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.72 | |||||
Operating Margin % | -298140.43 | |||||
Net Margin % | -263287.23 | |||||
EBITDA Margin % | -220759.57 | |||||
FCF Margin % | -212297.87 | |||||
OCF Margin % | -207812.77 | |||||
ROE % | -10.85 | |||||
ROA % | -10.53 | |||||
ROIC % | -225.01 | |||||
3-Year ROIIC % | -32.04 | |||||
ROC (Joel Greenblatt) % | -520.88 | |||||
ROCE % | -10.64 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 60100 | |||||
PB Ratio | 4.13 | |||||
Price-to-Tangible-Book | 4.19 | |||||
EV-to-EBIT | -28.14 | |||||
EV-to-EBITDA | -31.23 | |||||
EV-to-Revenue | 70243.91 | |||||
EV-to-FCF | -33.09 | |||||
Price-to-Projected-FCF | 146.59 | |||||
| Price-to-Net-Current-Asset-Value | 4.32 | |||||
| Price-to-Net-Cash | 4.44 | |||||
Earnings Yield (Greenblatt) % | -3.55 | |||||
FCF Yield % | -2.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinew Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 0.047 | ||
| EPS (TTM) (NT$) | -1.661 | ||
| Beta | -0.2467 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 83.82 | ||
| 14-Day RSI | 50.42 | ||
| 14-Day ATR (NT$) | 3.746904 | ||
| 20-Day SMA (NT$) | 57.955 | ||
| 12-1 Month Momentum % | 28.96 | ||
| 52-Week Range (NT$) | 29.05 - 85 | ||
| Shares Outstanding (Mil) | 71.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinew Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinew Pharma Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinew Pharma Inc Frequently Asked Questions
What is Sinew Pharma Inc(ROCO:6634)'s stock price today?
The current price of ROCO:6634 is NT$60.10. The 52 week high of ROCO:6634 is NT$85.00 and 52 week low is NT$29.05.
When is next earnings date of Sinew Pharma Inc(ROCO:6634)?
The next earnings date of Sinew Pharma Inc(ROCO:6634) is .
Does Sinew Pharma Inc(ROCO:6634) pay dividends? If so, how much?
Sinew Pharma Inc(ROCO:6634) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sinew Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers